4//SEC Filing
TAKEDA PHARMACEUTICAL CO LTD 4
Accession 0001395064-22-000040
$TAKCIK 0001783183other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 8:10 PM ET
Size
8.9 KB
Accession
0001395064-22-000040
Insider Transaction Report
Form 4
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2022-03-14+7,359,304→ 7,459,304 total - Exercise of In-Money
Warrants
2022-03-14−7,359,304→ 0 totalExercise: $0.00From: 2019-10-29Exp: 2029-05-07→ Common Stock (7,359,304 underlying) - Sale
Common Stock
2022-03-14$19.00/sh−18$342→ 7,459,286 total
Footnotes (1)
- [F1]On March 14, 2022, the Reporting Person exercised a Warrant to purchase 7,359,304 shares of the Issuers common stock with an exercise price of $0.00004613 per share. The Reporting Person paid the exercise price on a cashless basis in accordance with the terms of such Warrants, resulting in the Issuer withholding a number of shares (or portion thereof) to satisfy the exercise price and issuing to the Reporting Person the remaining number of shares. The Issuer also paid the Reporting Person $2.52 in lieu of a fractional share.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001395064
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 8:10 PM ET
- Size
- 8.9 KB